Zydus Wellness

₹476.85As of Sun 8 Nov 2026, 12:00 UTC

NSE:ZYDUSWELLConsumer Staples

Country India

PE (Fwd) 61.80

TSR 10Y CAGR 10.89%

Div yield 0.25%

ROE —

Packaged Foods

Beta (5Y) (0.06)

PE TTM 76.93

TSR TTM 0.25%

Mkt cap ₹149.1B

ROIC —

SE Grade™

—

Value

Quality

Moat

—

1Y Price

Reference

₹528

10.63%

(56.37%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

39.61

Revenue₹B

—

20.09

22.55

23.28

27.09

39.61

44.86

18.50%

46.22

Revenue growth%

—

12.23

3.24

16.37

46.22

13.25

14.30

—

100

59.86

Gross margin%

—

50.59

48.59

50.43

52.17

59.86

59.79

50.59

8.98

Operating margin%

—

16.03

13.86

12.21

12.99

8.98

8.91

12.99

4.98

Net margin%

—

15.37

13.77

11.47

12.81

4.98

4.93

12.81

76.93

P/E ratio (avg)x

—

40.56

32.69

37.28

36.08

69.01

68.63

37.28

42.65

EV/EBITx

—

38.90

32.47

35.00

35.58

38.26

37.95

35.58

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

6.20

EPS₹

—

9.71

9.76

8.39

10.90

6.20

6.95

(10.61%)

—

(43.15)

EPS growth%

—

0.50

(14.01)

29.97

(43.15)

12.10

(6.76)

—

Bookvalue per sh₹

—

FCF per share₹

—

1.20

Dividend per sh₹

—

1.00

1.20

1.25

4.66%

—

0.25

Div yield (avg)%

—

0.25

0.31

0.32

0.31

0.28

0.26

0.31

19.36

Payout ratio%

—

10.30

10.25

11.92

11.01

19.36

17.95

11.01

318.2

Shares (diluted)M

—

318.2

◌318.2

—

Buyback yield%

—

◌—

—

D/E ratiox

—

151.7

Enterprise value₹B

—

125.3

101.5

99.51

125.2

136.1

151.7

2.09%

—

LT debt₹M

—

Peers (US$1.589B)

Cap (US$)

LT Foods Limited

1.558B

22.28x

CCL Products (India)…

1.381B

28.03x

Manorama Industries…

1.310B

45.38x

Saudia Dairy & Foodstu…

1.595B

14.37x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

3.744

12.83

Own earn%

—

Sh yield%

0.25

0.31

Owners

Insiders/Inst%

0.85

22.63

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

4/4

EPS growth years

2/4

Dividend streakyrs

Op margin range%

9–16

$1 testx

—

Incr. ROIC%

—

Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in Asia, the Middle East, Africa, the Oceania, Europe, and North America.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹39.61B

18.50%

1.00×

Cost of revenue

₹15.90B

12.50%

0.81×

Operating expenses

₹20.15B

30.52%

1.47×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m